PDA

View Full Version : Phase II Multicenter Study of Docetaxel and Bevacizumab (Bev) +/- Trastuzumab for MBC


Hopeful
12-17-2010, 09:30 AM
Abstract:

http://www.abstracts2view.com/sabcs10/view.php?nu=SABCS10L_1100

Poster:

http://www.abstracts2view.com/sabcs10/viewp.php?nu=P6-12-08

Hopeful